Cite
Phase II studies of methyl glyoxal bis-guanylhydrazone (NSC 32946) in carcinoma of the colon and lung.
MLA
Killen, J. Y., et al. “Phase II Studies of Methyl Glyoxal Bis-Guanylhydrazone (NSC 32946) in Carcinoma of the Colon and Lung.” Cancer, vol. 50, no. 7, Oct. 1982, pp. 1258–61. EBSCOhost, https://doi.org/10.1002/1097-0142(19821001)50:7<1258::aid-cncr2820500706>3.0.co;2-1.
APA
Killen, J. Y., Mitchell, E. P., Hoth, D. F., Willis, L. L., Gullo, J. J., Smith, F. P., Schein, P. S., & Woolley, P. V. (1982). Phase II studies of methyl glyoxal bis-guanylhydrazone (NSC 32946) in carcinoma of the colon and lung. Cancer, 50(7), 1258–1261. https://doi.org/10.1002/1097-0142(19821001)50:7<1258::aid-cncr2820500706>3.0.co;2-1
Chicago
Killen, J Y, E P Mitchell, D F Hoth, L L Willis, J J Gullo, F P Smith, P S Schein, and P V Woolley. 1982. “Phase II Studies of Methyl Glyoxal Bis-Guanylhydrazone (NSC 32946) in Carcinoma of the Colon and Lung.” Cancer 50 (7): 1258–61. doi:10.1002/1097-0142(19821001)50:7<1258::aid-cncr2820500706>3.0.co;2-1.